Every year, at least 38,771 cervical cancer patients in India do not get the twin benefits of radiation and chemotherapy and suffer a poorer survival rate. These estimates were revealed in a multi-centre study conducted by the Bangalore-based National Centre for Disease Informatics and Research (NCDIR) — the premier research body of the Indian Council of Medical Research. The study, for the first time, analysed patterns of care and survival of cancer patients in India and found the quality of care wanting.
Dr A Nandakumar, Director of NCDIR, told The Indian Express the study confirmed many patients with locally advanced cervical cancers were not getting chemoradiation (RTCT). The study showed a distinctly better survival rate with RTCT, he said.
According to the study, annually 38,771 out of 75,873 ( or 51 per cent) patients with cancer of the cervix do not get the benefit of RTCT. Nandkumar said this number (38,771) was conservative as the results presented were based on treatment provided in some renowned cancer treatment centres, which are well-equipped in both facilities and skilled staff.
Cervical cancer comprises 7.92 per cent of cancers in women worldwide, and in India alone, estimates indicate there will be approximately 94,000 new cases per year.